Yiling to ramp up presence in global markets

Shijiazhuang Yiling Pharmaceutical Co Ltd, a high-tech enterprise, is looking to further expand its presence in overseas markets, especially those involved in the Belt and Road Initiative, with innovative approaches.

Founded in June 1992 by Wu Yiling, an academician from the Chinese Academy of Engineering, the company's product portfolio includes Chinese patent medicine, chemical drugs, pharmaceutical preparations and health products.

"Scientific and technological innovation has been the backbone of our strategy, and with traditional Chinese medicine gaining more popularity, we are ramping up our efforts to sell Chinese patent medicines to overseas markets, especially those related to the BRI," said Wu Xiangjun, chief executive officer of the company.